Short answer
Theravance Biopharma, Inc. (TBPH) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Item 2.02 reference indicates earnings or financial results disclosed via Exhibit 99.1.
Theravance Biopharma, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 reference indicates earnings or financial results disclosed via Exhibit 99.1
- Exhibit 99.1 must be reviewed separately for full earnings insight and performance metrics
- This filing act limits liability and regulatory incorporation, signaling preliminary or non-material nature of disclosure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Theravance Biopharma, Inc. 8-K filings
Get the next TBPH 8-K as it lands
Follow TBPH for push alerts, or ask the research agent what this filing means.